Health supplement sector
EZZ and Biome reached a new 52 weeks high today, in large volumes.
Another stock worth watching in this sector : Vista Life Science (VLS).
Unfortunately, there is a low level of liquidity for this stock, but first impression : it looks cheap (free cash flow yield above 10 %), while they had good results for FY 23 (financial year ends in December for them).
One difference between these 3 companies : their geographic exposure.
Biome almost only in Australia so far, but now expanding globally.
EZZ, mainly in mainland China so far (70 % of sales), but rapidly expanding in other Asian countries and about to enter North America.
Vista seems to be around 50/50 between Australia and Asia (mainly Malaysia and Singapore).
All these 3 companies are driven by a significant top line growth (10 % in FY 23 for Vista) and have already a good level of profitability (Vista and EZZ) or just reached profitability during the last 2 quarters (Biome). Capex requirements seem also quite limited in this sector.
- Forums
- Lounge
- Fund managers
Fund managers, page-1470
-
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)